{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:00:51Z","timestamp":1772244051385,"version":"3.50.1"},"reference-count":54,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2008.0137","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T04:46:35Z","timestamp":1525236395000},"source":"Crossref","is-referenced-by-count":5,"title":["Salicylate Intolerance"],"prefix":"10.3238","author":[{"given":"Hanns-Wolf","family":"Baenkler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2008,2,22]]},"reference":[{"key":"10.3238\/arztebl.2008.0137_ref1","doi-asserted-by":"crossref","unstructured":"Willis AL, Smith DL: Metabolism of arachidonic acid. In: Cunningham FM (ed.): The handbook of immunopharmacology and lipid mediators. London: Academic Press 1994; 1\u201332.","DOI":"10.1016\/B978-0-12-198875-3.50007-4"},{"key":"10.3238\/arztebl.2008.0137_ref2","doi-asserted-by":"crossref","unstructured":"Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis, diagnosis and management. J Allergy Clin Immunol 2003, 111: 913\u201320.","DOI":"10.1067\/mai.2003.1487"},{"key":"10.3238\/arztebl.2008.0137_ref3","doi-asserted-by":"crossref","unstructured":"Farooque S, Lee T: Mechanisms of aspirin-sensitive respiratory disease \u2013 as two component Model. Int Arch Allergy Immunol 2007; 142: 59\u201363.","DOI":"10.1159\/000095999"},{"key":"10.3238\/arztebl.2008.0137_ref4","unstructured":"Sch\u00e4fer D: Testing and typing of eicosanoid-patterns. J Physiol Pharmacol 2006; 57: 47\u201364."},{"key":"10.3238\/arztebl.2008.0137_ref5","doi-asserted-by":"crossref","unstructured":"Kaldenbach T, Sch\u00e4fer D, Gosepath J, Bittinger F, Klimek L, Mann WJ: Die Bedeutung eosinophiler Granulozyten in Beziehung zu Allergie und Aspirin-Intoleranz bei Patienten mit Sinusitis polyposa. Laryngo-Rhino-Otol 1999; 17: 429\u201334.","DOI":"10.1055\/s-2007-996903"},{"key":"10.3238\/arztebl.2008.0137_ref6","doi-asserted-by":"crossref","unstructured":"Sanz ML, Gamboa P, DeWeck A: A new combined test with flowcytometric basophile activation and determination of sulfidoleucotrienes is useful for in vitro diagnosis of hypersensitivity to Aspirin and other NSAID. Int Arch Allergy Immunol 2005; 136: 58\u201372.","DOI":"10.1159\/000082586"},{"key":"10.3238\/arztebl.2008.0137_ref7","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer D, Schmid M, G\u00f6de UC, Baenkler HW: Dynamics of eicosanoid in peripheral blood cells during bronchial, in: Aspirin-intolerant asthmatics. Eur Respir J 1999; 13: 638\u201346.","DOI":"10.1183\/09031936.99.13363899"},{"key":"10.3238\/arztebl.2008.0137_ref8","doi-asserted-by":"crossref","unstructured":"Schiavino D, Nucera E, Milani A, Del Ninno M, Buenomo A, Sun J, Patriarca G: The aspirin disease. Thorax 2000; 55: 66\u20139.","DOI":"10.1136\/thorax.55.suppl_2.S66"},{"key":"10.3238\/arztebl.2008.0137_ref9","unstructured":"Baenkler HW, Sch\u00e4fer D, Hosemann W: Eicosanoid pattern in nasal polyps and nasal mucosa. Rhinology 1996; 34: 166\u201370."},{"key":"10.3238\/arztebl.2008.0137_ref10","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer D, Lindenthal U, Wagner M, B\u00f6lcskei PL, Baenkler HW: Effect of prostaglandine E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 1996; 51: 919\u201323.","DOI":"10.1136\/thx.51.9.919"},{"key":"10.3238\/arztebl.2008.0137_ref11","doi-asserted-by":"crossref","unstructured":"Schmid M, G\u00f6de U, Sch\u00e4fer D, Wigand ME: Arachidonic acid metabolism in nasal tissue and peripheral blood cells in Aspirin-intolerant asthmatics. Acta Otolaryngol 1999; 119: 227\u201330.","DOI":"10.1080\/00016489950181819"},{"key":"10.3238\/arztebl.2008.0137_ref12","doi-asserted-by":"crossref","unstructured":"Gosepath J, Hoffmann F, Sch\u00e4fer D, Amedee RG, Mann WJ: Aspirin-intolerance in patients with chronic sinusitis. ORL 1999; 61: 146\u201350.","DOI":"10.1159\/000027660"},{"key":"10.3238\/arztebl.2008.0137_ref13","doi-asserted-by":"crossref","unstructured":"Puhlmann U, Sch\u00e4fer D, Ziemann C: Update on COX-2 inhibitor patents with focus on optimized formulation and therapeutic scope of drug combinations making use of COX-2 inhibitors. Expert Opin Ther Patents 2006; 16: 403\u201330.","DOI":"10.1517\/13543776.16.4.403"},{"key":"10.3238\/arztebl.2008.0137_ref14","unstructured":"Velten FW, Bayerl C, Baenkler HW, Schaefer D: Functional eicosanoid test and typing (FET) in acetylsalicylic acid intolerant patients with urticaria. J Physiol Pharmacol 2006, 57: 35\u201346."},{"key":"10.3238\/arztebl.2008.0137_ref15","unstructured":"Raithel M, Baenkler HW, Naegel A, Buchwald F, Schultis HW, Backhus B, Kimper S, Koch H, Mach E, Hahn EG, Konturek P: Significance of salicylate-intolerance in diseases of lower gastrointestinal tract. J Physiol Pharmacol 2005; 56: 89\u2013102."},{"key":"10.3238\/arztebl.2008.0137_ref16","doi-asserted-by":"crossref","unstructured":"May A, Weber A, Gall H, Kaufmann R, Zollner T: Means of increasing sensitivity of an in vitro diagnostic test for aspirin Intolerance. Clin Exp Allergy 1999; 29: 1402\u201311.","DOI":"10.1046\/j.1365-2222.1999.00655.x"},{"key":"10.3238\/arztebl.2008.0137_ref17","doi-asserted-by":"crossref","unstructured":"Ebo DG, Saint-Laudy A, Birdts CH, Mertens CH, Hagedorens MM, Schuerwegh AJ, De Clerck LS, Stevens WJ: Flow-assisted allergy-diagnosis: current application and future perspectives. Allergy 2006; 61: 1028\u201339.","DOI":"10.1111\/j.1398-9995.2006.01039.x"},{"key":"10.3238\/arztebl.2008.0137_ref18","doi-asserted-by":"crossref","unstructured":"Gamboa P, Sanz ML, Caballero MR, Urrutia I, Antepara I, Esparza R et al.: The flow-cytometric determination of basophile activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy 2004; 34: 1448\u201357.","DOI":"10.1111\/j.1365-2222.2004.02050.x"},{"key":"10.3238\/arztebl.2008.0137_ref19","doi-asserted-by":"crossref","unstructured":"Buhring HJ, Streble A, Valent P: The basophile-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell. Activation and allergy diagnosis. Int Arch Allergy Immunol 2004; 133: 317\u201329.","DOI":"10.1159\/000077351"},{"key":"10.3238\/arztebl.2008.0137_ref20","doi-asserted-by":"crossref","unstructured":"Hecksteden K, Sch\u00e4fer D, Stuck BA, Klimek L, H\u00f6rmann K: Diagnostik des Analgetika-Intoleranz-Syndroms mittels funktioneller Zelltestung. Allergologie 2003; 26: 263\u201371.","DOI":"10.5414\/ALP26263"},{"key":"10.3238\/arztebl.2008.0137_ref21","doi-asserted-by":"crossref","unstructured":"Gosepath J, Sch\u00e4fer D, Amadee RG, Mann WJ: Individual monitoring of aspirin desensitization. Arch Otolaryngol Head Neck Surg 2001; 12: 316\u201321.","DOI":"10.1001\/archotol.127.3.316"},{"key":"10.3238\/arztebl.2008.0137_ref22","doi-asserted-by":"crossref","unstructured":"Pfaar O, Klimek L: Aspirin desensitization in aspirin intolerance: update on current standards and recents improvements. Curr Opin Allergy Clin Immunol 2006, 6: 161\u20136.","DOI":"10.1097\/01.all.0000225153.45027.6a"},{"key":"10.3238\/arztebl.2008.0137_ref23","unstructured":"Schapowal A, Schmitz-Schumann M: Provokationstests bei aspirinsensitivem Asthma und aspirinsensitiver Rhinosinusits. Allergologie 1992: 15: 158\u201364."},{"key":"10.3238\/arztebl.2008.0137_ref24","doi-asserted-by":"crossref","unstructured":"Pearson DJ, Stones NA, Bentley SJ, Reid H: Proctocolitis induced by salicylate and associated with asthma and recurrent nasal polyps. Br Med J 1983; 287: 1675","DOI":"10.1136\/bmj.287.6406.1675"},{"key":"10.3238\/arztebl.2008.0137_ref25","unstructured":"Bergstr\u00f6m S: The prostaglandins: from the laboratory to the clinic. Nobel Lectures. Physiology or Medicine. Berichtszeitraum 1981\u20131990. Hrsg.: Jan Lindsten 1982; 93\u2013112."},{"key":"10.3238\/arztebl.2008.0137_ref26","unstructured":"Samuelson B: From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes. Nobel Lectures. Physiology or Medicine. Berichtszeitraum 1981\u20131990. Hrsg.: Jan Lindsten 1982; 117\u201338."},{"key":"10.3238\/arztebl.2008.0137_ref27","unstructured":"Vane JR: Adventures and excursions in bioassays: the stepping stones to prostacyclin. Nobel Lectures. Physiology or Medicine. Berichtszeitraum 1981\u20131990. Hrsg.: Jan Lindsten 1982; 145\u201370."},{"key":"10.3238\/arztebl.2008.0137_ref28","doi-asserted-by":"crossref","unstructured":"Settipane GA: Aspirin and allergic disease: a review. Am J Med 1983; 74: 102\u20139.","DOI":"10.1016\/0002-9343(83)90537-5"},{"key":"10.3238\/arztebl.2008.0137_ref29","doi-asserted-by":"crossref","unstructured":"Szczeklik A, Sanak M, Nizankowski E, Kielbasa B: Aspirin-intolerance and cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med 2004; 10: 51\u20136.","DOI":"10.1097\/00063198-200401000-00009"},{"key":"10.3238\/arztebl.2008.0137_ref30","doi-asserted-by":"crossref","unstructured":"Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. AJANE investigators European Network of aspirin-induced asthma. Eur Resp J 2000; 16: 432\u20136.","DOI":"10.1034\/j.1399-3003.2000.016003432.x"},{"key":"10.3238\/arztebl.2008.0137_ref31","unstructured":"May A, Zollner T, Weber A, Kaufmann R: Der Cellular Antigen Stimulations Test (CAST) in der Diagnostik Aspirin-sensitiver Rhinosinusitiden. Allergologie 2000; 23: 103\u20139."},{"key":"10.3238\/arztebl.2008.0137_ref32","doi-asserted-by":"crossref","unstructured":"Kahlert H, Cromwell O, Fiebig H: Measurement of basophile-activating capacity of grass pollen allergens, Allergoids and hypoallergenic recombinant derivates by flow cytometry Using anti-CD203c. Int Arch Allergy Immunol 2004; 133: 317\u201329.","DOI":"10.1046\/j.1365-2222.2003.01756.x"},{"key":"10.3238\/arztebl.2008.0137_ref33","doi-asserted-by":"crossref","unstructured":"Samter M, Beers RF: Concerning the nature of intolerance to Aspirin. J Allergy 1967; 40: 281\u201393.","DOI":"10.1016\/0021-8707(67)90076-7"},{"key":"10.3238\/arztebl.2008.0137_ref34","doi-asserted-by":"crossref","unstructured":"Becker JC, Domschke W, Pohle T: Current approaches to prevent NSAID-induced gastrophathy \u2013 COX selectivity and beyond. Br J Clin Pharmacol 2004; 58: 586\u2013600.","DOI":"10.1111\/j.1365-2125.2004.02198.x"},{"key":"10.3238\/arztebl.2008.0137_ref35","doi-asserted-by":"crossref","unstructured":"Hirschberg: Mitteilung \u00fcber einen Fall von Nebenwirkungen des Aspirin. DMW 1902; 28: 416.","DOI":"10.1055\/s-0029-1203577"},{"key":"10.3238\/arztebl.2008.0137_ref36","unstructured":"Widal MF, Abrani P, Lermoyez J: Anaphylaxie et idiosyncrasie. Presse Med 1922; 30; 189\u201392."},{"key":"10.3238\/arztebl.2008.0137_ref37","doi-asserted-by":"crossref","unstructured":"M\u00f6ller R, Paul E: Acetylsalicyls\u00e4ure als Augmentationsfaktor bei Nahrungsmittelallergien. Hautarzt 1996; 47: 281\u20133.","DOI":"10.1007\/s001050050415"},{"key":"10.3238\/arztebl.2008.0137_ref38","doi-asserted-by":"crossref","unstructured":"Chakroborty TK, Bhatia D, Heading RC, Ford MJ: Salicylate-induced exacerbation of ulcerative colitis. Gut 1987; 28: 613\u20135.","DOI":"10.1136\/gut.28.5.613"},{"key":"10.3238\/arztebl.2008.0137_ref39","doi-asserted-by":"crossref","unstructured":"Etienney I, Beaugerie L, Viboud C, Flahault A: Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: A case crossover study. Gut 2003; 52: 260\u20133.","DOI":"10.1136\/gut.52.2.260"},{"key":"10.3238\/arztebl.2008.0137_ref40","unstructured":"Higuchi T, Iwama T, Yoshinaga K, Toyooka M, Taketo MM, Sugihave K: A randomized, double blind, placebo controlled trial of the effects of Rolecoxib, a selective COX-2-inhibitor, on rectal polyps in familial adenomatous polyposis patients. Clin Cancer Res 2003, 9: 4756\u201360."},{"key":"10.3238\/arztebl.2008.0137_ref41","unstructured":"Baenkler HW, Sch\u00e4fer D: Abnormal eicosanoid pattern of peripheral white blood cells in gastrointestinal cancer. J Physiol Pharmacol 2005; 56: 119\u201328."},{"key":"10.3238\/arztebl.2008.0137_ref42","doi-asserted-by":"crossref","unstructured":"Konturek S, Piastucki I, Brzozowski T, Rodecki T, Dembinska-Kiec A, Zmuda A, Gryglewski R: Role of prostaglandins in the formation of Aspirin-induced gastric ulcer. Gastroenterology 1981; 80: 4\u20139.","DOI":"10.1016\/0016-5085(81)90182-7"},{"key":"10.3238\/arztebl.2008.0137_ref43","unstructured":"Baenkler HW, Zeus J, Schenk J, Sch\u00e4fer D: Abnormal eicosanoid pattern by blood leukocytes in gastroduodenal ulcer. Med Science Monitor 2004; 10: 447\u201356."},{"key":"10.3238\/arztebl.2008.0137_ref44","doi-asserted-by":"crossref","unstructured":"Gosepath J, Sch\u00e4fer D, Mann WJ: Analgetika-Intoleranz: Langzeitergebnisse bis zu 3 Jahren bei adaptativer Desaktivierung mit einer t\u00e4glichen Erhaltungsdosis von 100 mg Aspirin. Laryngo-Rhino-Otol 2002; 81: 732\u20138.","DOI":"10.1055\/s-2002-35002"},{"key":"10.3238\/arztebl.2008.0137_ref45","doi-asserted-by":"crossref","unstructured":"Erdmann SM, Vetocilla S, Moll-Slodowy S, Sauer I, Merk HF: Basophilen-Aktivierungstest in der Diagnostik von Arzneimittelrekationen. Hautarzt 2005; 56: 38\u201343.","DOI":"10.1007\/s00105-004-0871-8"},{"key":"10.3238\/arztebl.2008.0137_ref46","unstructured":"Baenkler M, Leykauf M, John S: Functional analysis of eicosanoids from white blood cells in sepsis and SIRS. J Physiol Pharmacol 2006; 57: 25\u201334."},{"key":"10.3238\/arztebl.2008.0137_ref47","doi-asserted-by":"crossref","unstructured":"H\u00e4berle M: Klinische und lebensmittelchemische Aspekte bei Unvertr\u00e4glichkeitsreaktionen auf Salizylat- und Additive-haltige Lebensmittel. Zbl Haut 1987; 153: 75\u201395.","DOI":"10.1007\/978-3-642-72829-7_10"},{"key":"10.3238\/arztebl.2008.0137_ref48","doi-asserted-by":"crossref","unstructured":"Thun MJ, Heuby SJ, Patrono C: NSAID as anticancer agents: mechanistic, pharmacologic and clinical issues. J Natl Cancer Inst 2002; 94: 252\u201366.","DOI":"10.1093\/jnci\/94.4.252"},{"key":"10.3238\/arztebl.2008.0137_ref49","doi-asserted-by":"crossref","unstructured":"Blacklock CJ, Lawrence JR, Wiles D, Malcolm EA, Gibson JH, Kelly CJ, Peterson JR: Salicylic acid in the serum of subjects not taking Aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians and patients taking low dose Aspirin. J Clin Pathol 2001; 54: 553\u20135.","DOI":"10.1136\/jcp.54.7.553"},{"key":"10.3238\/arztebl.2008.0137_ref50","doi-asserted-by":"crossref","unstructured":"Steinmetz KA, Potter JD: Vegetables, fruit and cancer: Epidemiology Cancer Causes Control 1991; 2: 325\u201347.","DOI":"10.1007\/BF00051672"},{"key":"10.3238\/arztebl.2008.0137_ref51","doi-asserted-by":"crossref","unstructured":"Calder PC: Immunomodulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Proc Nutr Soc 1996; 95: 727\u201334.","DOI":"10.1079\/PNS19960069"},{"key":"10.3238\/arztebl.2008.0137_ref52","doi-asserted-by":"crossref","unstructured":"Rodgers JB: n-3 fatty acids in the treatment of ulcerative colitis. In: Kremer J (ed.): Medical fatty acids in inflammation. Basel: Birkh\u00e4user Verlag 1998: 91\u2013101.","DOI":"10.1007\/978-3-0348-8825-7_7"},{"key":"10.3238\/arztebl.2008.0137_ref53","doi-asserted-by":"crossref","unstructured":"Cleland LG, James MJ, Proudman SM: The role of fish oils in the treatment of rheumatoid arthritis. Drug 2003; 63: 845\u201353.","DOI":"10.2165\/00003495-200363090-00001"},{"key":"10.3238\/arztebl.2008.0137_ref54","doi-asserted-by":"crossref","unstructured":"Swank RL, Dugan BB: Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990; 336: 37\u20139.","DOI":"10.1016\/0140-6736(90)91533-G"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2008.0137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T04:56:51Z","timestamp":1638853011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2008.0137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,22]]},"references-count":54,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2008.0137","relation":{"is-cited-by":[{"id-type":"doi","id":"10.3389\/fped.2018.00073","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,22]]}}}